Portal hypertension in a patient with chronic myeloid leukaemia
- PMID: 267281
- PMCID: PMC2496554
- DOI: 10.1136/pgmj.53.619.267
Portal hypertension in a patient with chronic myeloid leukaemia
Abstract
A patient with chronic myeloid leukaemia treated with busulphan for 4-5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice. At post-mortem there was minimal leukaemic infiltration but there were alterations in the liver architecture sufficient to explain the portal hypertension. The pathogenesis of the liver changes and their possible relationship to splenomegaly and busulphan toxicity are considered.
Similar articles
-
Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.Br J Haematol. 1991 Oct;79(2):185-92. doi: 10.1111/j.1365-2141.1991.tb04520.x. Br J Haematol. 1991. PMID: 1958475 Clinical Trial.
-
Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.Lancet. 1987 Nov 7;2(8567):1050-2. doi: 10.1016/s0140-6736(87)91478-4. Lancet. 1987. PMID: 2889964
-
Chronic myeloid leukaemia and a myasthenic syndrome.Acta Haematol. 1979;62(4):214-8. doi: 10.1159/000207574. Acta Haematol. 1979. PMID: 119414
-
Current concepts in the treatment of chronic myelocytic leukemia.Annu Rev Med. 1973;24:281-8. doi: 10.1146/annurev.me.24.020173.001433. Annu Rev Med. 1973. PMID: 4575858 Review. No abstract available.
-
[Portal hypertension in chronic lymphocytic leukemia].Rinsho Ketsueki. 1989 Dec;30(12):2169-72. Rinsho Ketsueki. 1989. PMID: 2695662 Review. Japanese.
Cited by
-
Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?Br J Cancer. 1993 Jul;68(1):186-90. doi: 10.1038/bjc.1993.311. Br J Cancer. 1993. PMID: 8318412 Free PMC article. Clinical Trial.